Dexmedetomidine Attenuates Neuropathic Pain in Chronic Constriction Injury by Suppressing NR2B, NF-κB, and INOS Activation

Overview

Journal Saudi Pharm J

Specialty Pharmacy

Date 2017 Jun 6

PMID 28579906

Citations 19

Authors

Feng Liang

Miao Liu

Xin Fu

Xueying Zhou

Peng Chen

Fanglei Han

Affiliations

Soon will be listed here.

Abstract

The effective treatment of patients suffering from neuropathic pain remains challenging. Dexmedetomidine (DEX) possesses anti-inflammatory activity. However, the role of DEX in neuropathic pain is still unclear. The aim of the present study was to examine DEX an α2-adrenoceptor agonist could improve pain hypersensitivity and reduce inflammatory in a chronic constriction injury (CCI) model of the sciatic nerve in Sprague-Dawley rats. Dex was intrathecally administrated 1-h after operation. The paw mechanical withdrawal threshold (MWT) and paw withdrawal thermal latency (PWTL) were measured on day 1 before operation and on days 1, 7, 14 and 21 after operation, respectively. On day 21, all the rats were decapitated to collect the L4-6 segments of the spinal cord to examine IL-1, TNF-α, IL-6, NR2B, NF-κB, and iNOS mRNA levels using RT-PCR. The postoperative MWT and PWTL were significantly decreased in CCI, and DEX groups as compared to those before surgery and Sham group (P < 0.05). And DEX reversed this trend (P < 0.05). Interleukin 1 (IL-1), tumor necrosis factor α (TNF-α), IL-6 mRNA expression significantly increased postsurgery in CCI group as compared to that of Sham group (P < 0.05); DEX blocked increased IL-1, TNF-α, IL-6, N-methyl-D-aspartate (NMDA) receptor 2B (NR2B), nuclear factor κB (NF-κB), and inducible isoform of nitric oxide synthase (iNOS) mRNA levels (P < 0.05). DEX may alleviate neuropathic hypersensitivity and inflammation partially by inhibiting NR2B, NF-κB, and iNOS expression in the spinal cord of rats with neuropathic pain resulting from CCI of the sciatic nerve.

Citing Articles

Progress on the Mechanisms and Neuroprotective Benefits of Dexmedetomidine in Brain Diseases.

Tao Z, Li P, Zhao X Brain Behav. 2024; 14(11):e70116.

PMID: 39482839 PMC: 11527817. DOI: 10.1002/brb3.70116.

The mechanism of Taohong Siwu decoction in treating chemotherapy-induced peripheral neuropathy: a network pharmacology and molecular docking study.

Zhou M, Liu L, Tan Y, Huang R, Yang Z Transl Cancer Res. 2024; 13(7):3842-3853.

PMID: 39145055 PMC: 11319946. DOI: 10.21037/tcr-24-1019.

CDDO regulates central and peripheral sensitization to attenuate post-herpetic neuralgia by targeting TRPV1/PKC-δ/p-Akt signals.

Lu C, Lin C, Lu Y, Tsai H, Lin C, Wu C J Cell Mol Med. 2024; 28(6):e18131.

PMID: 38426931 PMC: 10906387. DOI: 10.1111/jcmm.18131.

Chinese Tuina remodels the synaptic structure in neuropathic pain rats by downregulating the expression of N-methyl D-aspartate receptor subtype 2B and postsynaptic density protein-95 in the spinal cord dorsal horn.

Hongye H, BingQian W, Shuijin C, Jiayu F, Xiaohua W, Lechun C J Tradit Chin Med. 2023; 43(4):715-724.

PMID: 37454256 PMC: 10626369. DOI: 10.19852/j.cnki.jtcm.20221214.002.

The effect of dexmedetomidine on expression of neuronal nitric oxide synthase in spinal dorsal cord in a rat model with chronic neuropathic pain.

Pang J, Zhang S, Kong Y, Wang Z, Pei R, Zhuang P Arq Neuropsiquiatr. 2023; 81(3):233-239.

PMID: 37059432 PMC: 10104752. DOI: 10.1055/s-0043-1761491.

References

Ahn K, Sethi G, Aggarwal B . Nuclear factor-kappa B: from clone to clinic. Curr Mol Med. 2007; 7(7):619-37. DOI: 10.2174/156652407782564363. View

Zhang H, Zhou F, Li C, Kong M, Liu H, Zhang P . Molecular mechanisms underlying the analgesic property of intrathecal dexmedetomidine and its neurotoxicity evaluation: an in vivo and in vitro experimental study. PLoS One. 2013; 8(2):e55556. PMC: 3567091. DOI: 10.1371/journal.pone.0055556. View

Liu M, Zhou L, Chen Z, Hu C . Analgesic effect of iridoid glycosides from Paederia scandens (LOUR.) MERRILL (Rubiaceae) on spared nerve injury rat model of neuropathic pain. Pharmacol Biochem Behav. 2012; 102(3):465-70. DOI: 10.1016/j.pbb.2012.06.007. View

Zhou X, Cheng H, Xu D, Yin Q, Cheng L, Wang L . Attenuation of neuropathic pain by saikosaponin a in a rat model of chronic constriction injury. Neurochem Res. 2014; 39(11):2136-42. DOI: 10.1007/s11064-014-1407-y. View

Kalso E, Poyhia R, Rosenberg P . Spinal antinociception by dexmedetomidine, a highly selective alpha 2-adrenergic agonist. Pharmacol Toxicol. 1991; 68(2):140-3. DOI: 10.1111/j.1600-0773.1991.tb02052.x. View

He Z, Wei W, Li S, Ling Q, Liao K, Wang X . Anti-allodynic effects of obtusifolin and gluco-obtusifolin against inflammatory and neuropathic pain. Biol Pharm Bull. 2014; 37(10):1606-16. DOI: 10.1248/bpb.c14-00307. View

Jancalek R, Dubovy P, Svizenska I, Klusakova I . Bilateral changes of TNF-alpha and IL-10 protein in the lumbar and cervical dorsal root ganglia following a unilateral chronic constriction injury of the sciatic nerve. J Neuroinflammation. 2010; 7:11. PMC: 2828436. DOI: 10.1186/1742-2094-7-11. View

Marchand F, Perretti M, McMahon S . Role of the immune system in chronic pain. Nat Rev Neurosci. 2005; 6(7):521-32. DOI: 10.1038/nrn1700. View

Brummett C, Trivedi K, Dubovoy A, Berland D . Dexmedetomidine as a novel therapeutic for postoperative pain in a patient treated with buprenorphine. J Opioid Manag. 2009; 5(3):175-9. DOI: 10.5055/jom.2009.0018. View

10.

Grosu I, Lavandhomme P . Use of dexmedetomidine for pain control. F1000 Med Rep. 2011; 2:90. PMC: 3026617. DOI: 10.3410/M2-90. View

11.

Hylden J, Wilcox G . Intrathecal morphine in mice: a new technique. Eur J Pharmacol. 1980; 67(2-3):313-6. DOI: 10.1016/0014-2999(80)90515-4. View

12.

Baamonde A, Curto-Reyes V, Juarez L, Meana A, Hidalgo A, Menendez L . Antihyperalgesic effects induced by the IL-1 receptor antagonist anakinra and increased IL-1beta levels in inflamed and osteosarcoma-bearing mice. Life Sci. 2007; 81(8):673-82. DOI: 10.1016/j.lfs.2007.07.003. View

13.

Farghaly H, Abd-Ellatief R, Moftah M, Mostafa M, Khedr E, Kotb H . The effects of dexmedetomidine alone and in combination with tramadol or amitriptyline in a neuropathic pain model. Pain Physician. 2014; 17(2):187-95. View

14.

Bennett G, Xie Y . A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988; 33(1):87-107. DOI: 10.1016/0304-3959(88)90209-6. View

15.

Moalem G, Tracey D . Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev. 2006; 51(2):240-64. DOI: 10.1016/j.brainresrev.2005.11.004. View

16.

Hargreaves K, Dubner R, Brown F, Flores C, Joris J . A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988; 32(1):77-88. DOI: 10.1016/0304-3959(88)90026-7. View

17.

Lv C, Hu H, Zhao L, Zheng H, Luo X, Zhang J . Intrathecal SRT1720, a SIRT1 agonist, exerts anti-hyperalgesic and anti-inflammatory effects on chronic constriction injury-induced neuropathic pain in rats. Int J Clin Exp Med. 2015; 8(5):7152-9. PMC: 4509198. View

18.

Qu X, Cai J, Li M, Chi Y, Liao F, Liu F . Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain. Exp Neurol. 2008; 215(2):298-307. DOI: 10.1016/j.expneurol.2008.10.018. View

19.

Sun T, Song W, Fu Z, Liu Z, Liu Y, Yao S . Alleviation of neuropathic pain by intrathecal injection of antisense oligonucleotides to p65 subunit of NF-kappaB. Br J Anaesth. 2006; 97(4):553-8. DOI: 10.1093/bja/ael209. View